Ginkgo biloba extract (Egb761) attenuates zinc-induced tau phosphorylation at Ser262 by regulating GSK3β activity in rat primary cortical neurons
- 13 May 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 6 (6) , 2058-2067
Abstract
In the brain, an excessive amount of zinc promotes the deposition of β-amyloid proteins and the intraneuronal accumulation of neurofibrillary tangles composed of hyperphosphorylated tau proteins. These consequences are key neuropathological traits that reflect Alzheimer's disease. Egb761, a standardized Ginkgo biloba extract, is a powerful antioxidant known to exhibit neuroprotective actions. In this study, we investigated whether Egb761 can counteract the zinc-induced tau phosphorylation in rat primary cortical neurons. To determine the modification of tau phosphorylation by Egb761 treatment, we conducted Western blot analyses, MTT assay, ROS measurements and immunocytochemistry. We found that zinc-induced tau phosphorylation occurred at Ser262 in a time- and dose-dependent manner while other tau sites were not phosphorylated. Tau phosphorylation at Ser262 was increased 30 min after zinc treatment and peaked 3 h after zinc treatment (control: 100 ± 1.2%, 30 min: 253 ± 2.24%, 3 h: 373 ± 1.3%). Interestingly, Egb761 treatment attenuated the zinc-induced tau hyperphosphorylation at Ser262 in a concentration-dependent manner while the antioxidant N-acetylcysteine showed a similar effect. Furthermore, Egb761 prevented the zinc-induced activation of p38 MAPK and GSK3β, as well as the zinc-induced increase in ROS production and neuronal cell death. Lithium chloride also inhibited the zinc-induced tau phosphorylation but did not affect ROS levels. These results suggest the potential of Egb761 for inhibiting the zinc-induced tau phosphorylation at Ser262 through its anti-oxidative actions involving the regulation of GSK3β. Therefore, Egb761 may be a candidate for the treatment of tauopathy present in neurological disorders such as Alzheimer's disease.Keywords
This publication has 51 references indexed in Scilit:
- Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin‐dependent kinase 5 activity in SH‐SY5Y neuroblastoma cells and primary neuronsJournal of Neurochemistry, 2013
- Tau Ser262 phosphorylation is critical for A 42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's diseaseHuman Molecular Genetics, 2010
- Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against β-amyloid peptide-induced toxicity in SH-SY5Y cellsChemico-Biological Interactions, 2009
- Dosage effects of EGb761 on hydrogen peroxide-induced cell death in SH-SY5Y cellsChemico-Biological Interactions, 2009
- Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Ginkgo Biloba Extract Neuroprotective Action Is Dependent on Heme Oxygenase 1 in Ischemic Reperfusion Brain InjuryStroke, 2008
- The GSK3 hypothesis of Alzheimer’s diseaseJournal of Neurochemistry, 2007
- Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase‐3β activationFEBS Letters, 2005
- Reactivating Kinase/p38 Phosphorylates τ Protein In VitroJournal of Neurochemistry, 1997
- Production of congenital malformations using tissue antisera: XV. Reichert's membrane and visceral yolk sac antiseraDevelopmental Biology, 1975